
    
      A prospective, open-label, non-interventional, multicentre study in adult patients with
      asthma or COPD who are treated with Salmeterol/fluticasone Easyhaler. During the study the
      Salmeterol/fluticasone Easyhaler will be used according to the Summary of Product
      Characteristics. Clinical effectiveness of the treatment will be evaluated with change in
      asthma or COPD symptoms during 12 weeks treatment.
    
  